Immunostimulator for animals and humans, and method of preventing animal and human infectious diseases and cancer

Abstract

The goal of the present invention is to provide substances to prevent diseases by activating inherently possessed functions, for cultured fishes and shellfishes and livestock with tendency of decreased immune function due to densely populated breeding environment, and for humans with tendency of easily lowered immune functions due to complicated social structures and aging. The present invention expresses marked effect in preventing infection and cancer by administrating appropriate dose of swine plasma, swine plasma albumin, peptides isolated from swine plasma and swine plasma albumin, and swine plasma mixture, among others including fine powder of Crustacea (including crust of Crustacea), to activate immune function of Crustacea, Pisces, Aves, Mammals, and humans.

We claim:  
     
         1 . An immunostimulator for animals and humans, comprising: swine plasma, said swine plasma characterized in expressing immunostimulative activity, preventing effect on infectious disease, and anti-tumor effect on Crustacea, Pisces, animals other than Crustacea and Pisces, and humans.  
     
     
         2 . An immunostimulator according to  claim 1  containing swine plasma albumin.  
     
     
         3 . An immunostimulator for animals and humans according to  claim 1  comprising swine plasma or peptides purified from swine plasma albumin.  
     
     
         4 . An immunostimulator according to  claim 1  comprising an ingredient selected from the group consisting of fine-powdered Crustacea, fine-powdered crust of Crustacea, purified material from Crustacea, and crust of Crustacea.  
     
     
         5 . An animal feed comprising the immunostimulator of  claim 1 .  
     
     
         6 . A veterinary pharmaceutical comprising the immunostimulator of  claim 1 .  
     
     
         7 . A food or beverage product comprising the immunostimulator of  claim 1 .  
     
     
         8 . A pharmaceutical for human use comprising the immunostimulator of  claim 1 .  
     
     
         9 . A method of preventing infectious disease and cancer in animals and humans comprising: administrating to the animal or human the immunostimulator of  claim 1 .  
     
     
         10 . A method according to  claim 9  whereby the immunostimulator is administered to the animal or human in a one-day dose ranging between 1-3000 mg/kg.  
     
     
         11 . A method according to  claim 10  whereby the immunostimulator is swine plasma albumin-derived peptide, and the dose ranges between 1-300 mg/kg.  
     
     
         12 . A method according to  claim 11  whereby the immunostimulator is administered in a dose ranging between 5-100 mg/kg.  
     
     
         13 . A method according to  claim 10  whereby the immunostimulator is swine plasma albumin, and the dose ranges between 30-1000 mg/kg.  
     
     
         14 . A method according to  claim 13  whereby the immunostimulator administered in a dose ranging between 70-500 mg/kg.  
     
     
         15 . A method according to  claim 10  whereby the immunostimulator is selected from the group consisting of swine plasma, swine plasma mixed with fine-powdered Crustacea, and crust of Crustacea, and the dose ranges between 100-3000 mg/kg.  
     
     
         16 . A method according to  claim 15  whereby the immunostimulator is administered in a dose ranging between 200-1200 mg/kg.  
     
     
         17 . A method according to  claim 10  whereby the immunostimulator is administered through a route selected from the group consisting of feed, veterinary pharmaceuticals, beverages, food, health food, and pharmaceuticals.